The present application relates to novel substituted 5-fluoro-lH-pyrazolopyridines, to processes for preparation thereof, to the use thereof alone or in combination for treatment and/or prophylaxis of disorders, and to the use thereof for production of medicaments for treatment and/or prophylaxis of disorders, especially for treatment and/or prophylaxis of cardiovascular disorders.